MYC Amplification-Conferred Primary Resistance to Capmatinib in a MET-amplified NSCLC Patient: a Case Report
Translational Lung Cancer Research（2022）
Key words
Capmatinib,mesenchymal-epithelial transition factor (MET),MYC,lung cancer,case report
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined